Peptides International's Poster Presentation for the 2015 American Peptide Symposium

APS Poster News

Be sure to stop by our booth (# 33) and poster at the 2015 American Peptide Symposium in Orlando June 20- June 25, 2015. Our poster describes the progress of our NIH grant funded research on developing novel Kv1.3 selective peptides for treating Multiple Sclerosis and other autoimmune diseases. Over the past two decades, we have utilized our experience at synthesizing disulfide rich peptides isolated from venoms as potential treatments for animal models of autoimmune diseases. In particular, Dalazatide, an analog of the sea anemone-derived ShK peptide has recently completed phase 1B human trials. Our poster describes the continuation of our work, designing more Kv1.3 selective ShK peptides.

You can view it here: https://www.pepnet.com/res/uploads/media/APS-2015-poster.jpg

 

 

Industry News , Biologically Active Peptides , Peptides International News

Robert Brousseau

See all articles from Robert Brousseau

Robert Brousseau, the Director of Marketing and Catalog Sales Development at Peptides International, has a wide range of responsibilities that include maintaining the Peptides International brand integrity and creating and implementing all materials related to marketing the company's product line. He is also tasked with the catalog portfolio sales.  Since joining the company in 2004, he has incorporated media that now includes printed material such as product brochures and the long-running PEPNET newsletter, along with the company Website, social media, email and other outlets.  Additionally, he assists the staff with IT issues they encounter.  Bob has a background in graphic design, marketing, and advertising, in addition to project management and packaging.  He received his B.A. in Art from the University of Louisville, with additional post-graduate studies in education and design.